Implementation of CxCa Screening program in Uzbekistan

801 views

Published on

Working meeting on Comprehensive Cervical Cancer Prevention and Control in UNFPA EECARo and ASRO Countries

Implementation of CxCa Screening program in UZbekistan

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
801
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Implementation of CxCa Screening program in Uzbekistan

  1. 1. WORKING MEETING ON COMPREHENSIVE CERVICAL CANCER PREVENTION ANDCONTROL IN UNFPA EECARO AND ASRO COUNTRIES Implementation of CxCa screening program in Uzbekistan Antalya, Turkey 18-20 May 2011
  2. 2. MAGNITUDE AND BURDEN OF CERVIVAL CANCER IN UZBEKISTAN
  3. 3. Rationale for initiating national program for cervical cancer and control• Total morbidity rate due to cervical cancer -8,4 (per 100,000 population)• Early detection at 0-1 stages -10%• Cervical cancer cases detected at II-IV stages – 83% (MoH)
  4. 4. Health System Structure and entry points for CxCa programs• Health care system reforms started in 1998 and enabled integration of SRH at PHC level• GPs and midwives are key in provision of SRH services National Ob/GYN Center Cytology labs at regional level (PAP tests (control and interpretation) establishment of national PHC clinics database) (Smears collection, transportation) National Oncology Center Oncology dispensaries at (treatment and follow-up regional level care)
  5. 5. HEALTH SYSTEM STRENGTHENING APPROACH for CERVICAL CANCER PREVENTION AND CONTROLCHALLENGES ACTIONS TAKEN•Low technical capacity of health care •UNFPA took a leadership insystem to apply secondary screening introduction of cytological screening•Lack of financing to cover the needed (Pap test)age cohort of female population by Pap •Small scale study on cost –benefitscreening analysis on implementing of a National•National program to support CxCa Cancer Screening program is conductedcontrol and prevention is not in place •MoH is in charge to monitor andyet ( at stage of pilot projects supported analyze the results of pilot projectsby donors) •Referral system is established for•CxCa problem is still under priority of control and monitoringspecialized oncology services with low •Practical guidelines for PHC health caresensitization on prevention and providers and lab technicians ismonitoring developed•Only 25% of women in age 30-65 willcovered under pilot project by Pap testin 5 pilot regions
  6. 6. Age groups to be covered and cost - benefitanalysis of implementation of Pap screening
  7. 7. Ways forward/ future plans• Capacity building (trainings for lab specialists, Ob/Gyns and midwives, including in-job trainings)• Data base establishment and monitoring at regional and national level within 5 regions• Improvement technical capacity of PHC and specialized clinics/labs through procurement of essential supplies for Pap tests, colposcopy and LEEP• Advocacy activities to develop sustainable mechanisms to establish screening and control system nationwide
  8. 8. Thank You!

×